Esbriet - Drug Details
๐Ÿ“Š Estimates Esbriet Dialyzability By Different_Modalities

Esbriet

Complete Drug Information

Drug Name
Esbriet
Trade Names
Esbriet, Pirespa, Etuary
Pregnancy Category
AU: B3
Routes of Administration
Oral
Protein Binding
50โ€“58%%
Metabolism
Liver (70โ€“80% CYP1A2-mediated; minor contributions from CYP2C9, CYP2C19, CYP2D6 and CYP2E1)
Elimination
2.4 hours
Excretion
Urine (80%)
Formula
C12H11NO
Molar Mass
185.226
Volume of Distribution
C12H11NO

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.